The session will be conducted in the style of the BBC Radio 4 Moral Maze discussion programme, with panelists and witnesses arguing for and against the viewpoint corporatisation is inevitable and will benefit vets and their clients.
Moderated by Madeleine Campbell, Keith Chandler and Karl Holliman will argue for corporatisation and Andrew Harrison and Tim Greet will be against. They will call upon a series of 'witnesses' for detailed questioning before the topic is more broadly debated.
CVS, the UK’s biggest veterinary group now owns more than 410 veterinary practices, of which over 30 are specifically equine or mixed practices.
The latest equine acquisitions include Bell Equine, a one-site Equine Referral Hospital in Kent, in January 2017 and Severn Edge Veterinary Group, a mixed practice with 12 sites in Shropshire, including a six-vet dedicated equine practice, in April 2017.
One line of argument says that the commercial and business advantages of a corporate, together with their scale and diversity, can give veterinary surgeons greater potential for a more flexible career path and advancement within the industry, and a more sustainable working career in equine practice.
On the flip side, there's the removal of any opportunity to buy into ownership, reduced decision-making ability because of adherence to corporate procedures, extra paperwork, longer approval processes and an increased emphasis on the bottom line.
David Mountford, Chief Executive of BEVA said: "The auditorium is usually full to bursting for our Moral Maze sessions because they bring a broader and more engaging dimension to important topics. The statement Corporatisation of equine practices is inevitable and will benefit vets and their clients is bound to generate some stimulating and possibly heated debate."
This year's BEVA Congress will be held at Liverpool Arena Convention Centre, and anyone who registers before 3rd August will receive significantly reduced booking fees.
For more information, visit: www.beva.org.uk.
The poster was put together by a team of 55 specialists and general practitioners led by Fergus Allerton.
It includes an outline of the new European Medicines Agency advice on categorising antibiotics, a new section on wounds and surgical site infections, updated advice on life-threatening infections and identifying/treating sepsis, and more advice for owners.
Fergus said: “The latest iteration of the PROTECT ME poster incorporates updated information and offers recommendations to support vets to optimise their antibiotic use.
"I hope this will be a valuable resource for vets in practice.”
The new posters will be distributed with Companion in December.
Free printable posters are available from: www.bsavalibrary.com/protectme
Printed copies can be purchased from the BSAVA store: www.bsava.com/store.
BSAVA members are also able to request free printed copies.
The RCVS Disciplinary Committee has dismissed a charge against Nicholas Robert William Horniman MRCVS, a veterinary surgeon from Cinderford, Gloucestershire, that alleged he was guilty of pet insurance fraud, along with one of his clients, and of dishonestly altering clinical records.
The charge was that, between December 1 2008 and June 30 2014, in relation to Cassy, a Labrador retriever belonging to Jayne Bowkett, Mr Horniman:
The Committee heard that Cassy, who had previously been diagnosed with hip dysplasia, had been registered with Pets Barn Veterinary Group in Gloucestershire in May 2008 when Mr Horniman was the Principal and owner of the three-practice group. Cassy was treated at the Cinderford branch of the practice where she received regular prescriptions for her condition.
At some point in 2008/2009, Mrs Bowkett had relayed concerns to Mr Horniman that her current pet insurance policy needed to be renewed, that the renewed policy would not cover Cassy's existing hip problems and that she would be unable to pay for any future operations herself. It was alleged that, in response to Mrs Bowkett's concerns, Mr Horniman told her that they could take Cassy off the practice computer and put her back on under a different insurance policy in a different name.
Mrs Bowkett took out a policy with Petplan, beginning on 13 August 2009, using her father's details instead of her own. It was alleged that Mr Horniman then arranged for new practice records to be set up in the name 'Cassy Griffiths'. These new records were first used substantively in May 2010 when Cassy returned to the practice with hip problems, following which two separate records were maintained for the dog under 'Cassy Bowkett' and 'Cassy Griffiths'.
In August 2010 Dariusz Drozdz MRCVS, a vet who had treated Cassy several times, had been told by Mrs Bowkett that the dog had two separate records. He told the Disciplinary Committee that he queried this with Mr Horniman who suggested that it was a mistake and that they 'RIP' the name Cassy Bowkett. Mr Drozdz disagreed on this course of action but was told by Mr Horniman to 'leave it to me' and the records were then changed to say that Cassy Bowkett had died.
Mrs Bowkett alleged that, at some point in 2011, Mr Horniman explained to her that it would no longer be possible to claim for treatment for Cassy's hip dysplasia under the Petplan policy in her father's name. However, the policy remained active, and was transferred into Mrs Bowkett's name upon her father's death.
In July 2011 Cassy Griffiths was seen by Jennifer Jones MRCVS, a part-time locum vet at the Cinderford practice, who told the Committee that she was puzzled about why there were very few clinical records relating to the animal. A receptionist explained to her that there were two sets of records for the same dog and that Mr Horniman had instructed her to mark the original pet as having been euthanased and close its records and create a second new record for the dog. Ms Jones tendered her resignation shortly afterwards citing concerns that a pet had been 'reincarnated to ensure continued income from insurance claims'. In November 2011 Ms Jones submitted a formal complaint to the RCVS.
During the course of the hearing the Committee heard evidence from Mrs Bowkett, Mr Drozdz and Ms Jones, amongst others.
In giving evidence Mrs Bowkett admitted that she had knowingly engaged in fraud but maintained that at all times she had acted with the knowledge and on the advice of Mr Horniman. However, the Committee found that she was unable to remember any relevant material dates and was unclear about the chronology of events. It was suggested on several occasions that she was lying to the Committee, which she denied. However, the Committee believed that she took no responsibility for her own fraudulent actions but merely blamed Mr Horniman and that she had a strong motive to engage in the insurance fraud.
In regards to the evidence given by Mr Drozdz the Committee noted that he did not record his suspicions of possible fraud, that he continued to treat Cassy Griffiths after he raised his concerns, and that he appeared to have accepted Mr Horniman's assurance that he had dealt with the issue.
The Committee found that Ms Jones was correct in her suspicions that there was only one dog. However, it felt she offered no evidence to support her suspicion that this was part of Mr Horniman's 'scheme to maximise income for the practice' as she alleged in her witness statement.
The Committee also heard oral evidence from and on behalf of Mr Horniman who categorically denied suggesting to Mrs Bowkett that she commit insurance fraud and attempting to cover this up through the maintenance of two separate records. He maintained that it was not until Ms Jones voiced her concerns that he realised that Cassy Bowkett and Cassy Griffiths were the same dog.
The Committee voiced a number of concerns about Mr Horniman's actions and behaviour and, at times, found his evidence to be unsatisfactory. For example, the Committee found it difficult to understand why 'alarm bells' did not ring that he was dealing with only one dog when he prescribed medication for two almost identical dogs in May 2010 when only one was presented for examination. It also queried why, when he became aware that the insurance policy for Cassy Griffiths was fraudulent, practice records were not updated and no attempt was made to contact Petplan to inform them of this, as is clearly advised by the RCVS Code of Professional Conduct.
Furthermore, the Committee was concerned that, in his correspondence with the RCVS, he was less than transparent, candid and honest. The Committee considered this to be unacceptable behaviour from a professional in dealings with investigations undertaken by the regulatory body.
In making its judgment, the Committee had to make a decision on whose account it felt to be more reliable in regards to the first element of the charge.
Noreen Burrows, chairing the Committee and speaking on its behalf, said: "In coming to its conclusion ... the Committee is faced with conflicting evidence from Mrs Bowkett, who is an admitted fraudster, admits to acting dishonestly and to lying to Petplan. This is in contrast to the evidence from the Respondent, who is of good character, had an unblemished personal record over 23 years and is supported by impressive character references."
The Committee found the evidence of Mrs Bowkett to be "vague, lacking in clarity and inconsistent with the facts" and therefore rejected her evidence concerning the first element of the charge. In regards to the second element of the charge, the Committee was not satisfied that Mr Horniman had arranged for or allowed the records to be changed as was alleged. In regards to the third element it found that, since it had already rejected the charge that Mr Horniman suggested to Mrs Bowkett that she embark upon insurance fraud, it was unlikely that Mr Horniman would have acted dishonestly in the manner alleged.
Noreen Burrows added: "In the light of the above findings, all charges against the Respondent are dismissed."
The Royal Veterinary College has carried out the first ever open-heart surgery to treat a stenotic tricuspid valve in a dog.
The three-year-old Labrador, Mabel, suffered from congenital tricuspid dysplasia. She was referred to cardiology specialists at RVC Small Animal Referrals where her tricuspid valve was found to be completely fused in the middle, with just two very small openings for her blood to flow through.
In a procedure that took a little over an hour, the RVC team examined and worked on the valve. The College reports that Mabel’s surgery was a success and her stenosis was relieved.
Mabel was subsequently found to have a moderate amount of regurgitation into the right atrial chamber, but after a few more days of additional monitoring at the RVC she was able to return home.
The surgery was carried out by Professor of Small Animal Surgery Dan Brockman at the Queen Mother Hospital for Animals. He was assisted by a team of RVC specialists to provide pre and post-operative care, including a perfusionist, a team of three anaesthetists, two surgery nurses, three surgeons and a cardiology veterinary specialist-in-training. In addition, Professor of Veterinary Cardiology Virginia Luis Fuentes and veterinary specialist-in-training Dr Rosie Payne were members of the Cardiology Service’s investigation into Mabel’s condition.
RVC students were also involved in the Mabel’s initial examinations at the hospital, providing them with an insight into the procedure. The examinations included cardiac ultrasound using the newest generation of cardiac ultrasound equipment, which is able to capture 3D and 4D images. The new ultrasound scanner was funded in part by the RVC’s charity, the Animal Care Trust.
After the surgery, the emergency and critical care (ECC) team and the Cardiology Service took over Mabel’s care, with Professor Brockman remaining involved. This saw up to four senior ECC clinicians, a number of veterinary specialists-in-training and half a dozen highly trained ECC technicians working in shifts around the clock to care for Mabel and ensure a good recovery.
According to the RVC, there have been previous attempts by veterinary surgeons to open stenotic valves with balloon valvuloplasty. However, because it is very difficult to tear the stenotic valve, this approach has not proved very successful. There is also a high risk when putting canines onto bypass. Canines have fragile blood vessels, and cannulae need to be inserted into several of these vessels, creating a danger that a major vessel tears.
Commenting on why the RVC team decided to perform this procedure at this point, and on Mabel, Dan said: "Lots of things fed into this decision. First and foremost, we had a patient whose pathology made surgery the best solution. I explained to the owner and was very honest that this procedure would be really breaking new ground. Based on what the human paediatric cardiac surgeons will do, and our limited experience of balloon-valvuloplasty suggests this is the best approach for these dogs
"The operation itself is risky, much worse than most other operations. In our hands, for this type of disease, we have about an 80% chance of getting them through the procedure. The owner has to gamble what life the dog has left against the promise of a more normal quality of life and life-span following the operation."
In relation to Mabel’s prognosis if the surgery had not been undertaken, Professor Luis Fuentes said: "It is likely that the signs of right-sided heart failure would have been more difficult to control. Her ability to exercise would have become less and less, and she would have also been at risk of having abnormal heart rhythms associated with the enlargement of the right atrium. Generally we expect them to develop more and more signs as the disease progresses. These are difficult cases to manage on a long-term basis with drugs. Her life expectancy would have been substantially reduced.
"I thought Mabel was almost a perfect candidate to have the procedure here as Dan has a lot of experience replacing tricuspid valves in dogs with tricuspid dysplasia. In those cases there is usually leaking, but Mabel’s case was unusual in that she has minimal leaking and she was most affected by the stenosis. That means you may not have to implant any additional valve structure."
Speaking two weeks after the operation, owner Annabelle Meek, from Melton Mowbray, said: "Mabel has just come back in from wandering around the perimeter of my garden for the first time since before the operation. It’s more than half an acre and she has been ambling around happily following a scent.
"I would like to thank absolutely everybody. It’s been an enormous team effort on all sides. Every single person I met at the RVC, from the man on the gate to all the hospital staff, was so friendly. After she came home Dan Brockman phoned me every day to see how she was doing. The RVC should be very proud of what they have done for Mabel."
The first meeting takes place on Thursday 27th May from 12.30pm to 1.30pm. It will look at how veterinary practices have had to work differently and adapt to the challenges posed by the coronavirus pandemic.
Chris Tufnell, RCVS Council Member and Innovation Lead (pictured right), will be chairing the session. He said: “In the past 15 months we have been in innovation overdrive, adapting at a unprecedented pace to transform how we work, serve our clients and patients, and continue to function as veterinary businesses in less-than-ideal circumstances.
"This event is an opportunity to take a step back, look at what has happened, how we have changed and consider what aspects of these changes we might carry over when we return to near normal working conditions.
"For those who join us, we would like to know what kind of innovation solutions you and your colleagues have developed, and share your stories and ideas to help and inspire others.”
Joining Chris on the panel will be a selection of veterinary professionals who will share their own experience of how they have had to adapt the way they work during the pandemic. Participants include Anita Patel, an RCVS-recognised Specialist in Veterinary Dermatology, who runs her own dermatology referral service, and Richard Artingstall, Clinical Director of Vale Referrals in Gloucestershire.
The event, which will feature short presentations followed by a reflective discussion, is free to attend and can be signed up to via its Eventbrite page at: www.eventbrite.co.uk/e/152857028487
More meetings are planned for later in the year:
If you have any questions about the sessions or would like to take part as a speaker, email the ViVet Manager, Sophie Rogers on s.rogers@rcvs.org.uk or info@vivet.org.uk
The webinars will be presented by specialists in their respective fields; small animal oncologist Sara Verganti and clinical pathologists Francesco Cian and Roberta Rasotto.
Each 30-minute session will focus on a specific aspect of MCT diagnostics followed by a multidisciplinary Q&A. The sessions, which all start at 7:30pm, are:
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Mast cell tumours are the most common form of canine cutaneous neoplasia, although relatively simple to identify, knowing what diagnostic steps to take can be challenging. We believe this truly comprehensive bite size mini-series will provide vets with the confidence to navigate the diagnostic approach for their next MCTs."
For more information, contact your Virbac Territory Manager.
The survey, conducted among 130 veterinary professionals around the UK, including vets, nurses, receptionists and practice managers, revealed that on-demand video-based CPD ranked as the top choice of learning platform for 47% of respondents, while online text-based learning was next at 22%.
15% preferred in-person workshops and 10% in-practice training.
Meanwhile, only 6% preferred live lunchtime or evening webinars, and only 1% event lectures.
The survey identified that the most popular non-clinical CPD topics were complaint management (57%), communication (43%) and customer service (44%).
Barriers to the more widespread adoption of online learning platforms within practices were cost (70%) and a lack of time for CPD completion (80%) as a significant challenge.
Emma Barnes, Managing Director for Veterinary at Agilio, said: “The veterinary workforce is stretched and finding time to attend in-person CPD can be challenging.
"Flexible online solutions that accommodate busy schedules empower vets, nurses and the wider practice team to fulfil their CPD requirements whenever and wherever they choose.”
https://agiliosoftware.com
European veterinary practitioners are to receive guidance on the appropriate use of the fluoroquinolone group of antibiotics in treating a wide range of common diseases in companion animals.
The advice has been drawn up by the REQUEST team, a multinational and multidisciplinary group of experts which met for the third time last November. Their recommendations have been designed to help ensure the continued availability of this class of antibiotics in both veterinary and human medicine.
The REQUEST initiative aims to achieve a consensus on when and how to prescribe fluoroquinolones, based on a detailed assessment of published scientific data by its panel of nine acknowledged international experts. Following earlier meetings in Lyon and Vienna they have reached a stage in this ongoing project in which they can offer specific guidance on the use of fluoroquinolones in treating three important conditions in dogs: pyoderma, bacterial diseases of the upper respiratory tract and lower urinary tract infections. They will also be offering guidance on the appropriate use of this class of antibiotics in cats to avoid the development of retinal toxicities, which may occasionally result from treatment with one particular fluoroquinolone drug, enrofloxacin.
The guidance will be presented in papers to be submitted to those scientific journals which will be easily accessible to veterinary practitioners throughout Europe. Further papers will be produced and translated into the main European languages giving guidance on fluoroquinolones use in other important bacterial conditions in dogs and cats.
In the later stages of the project, the team will be highlighting priorities for future research and will use its influence to encourage collaborative studies involving the animal health industry, practitioners, veterinary schools and other research institutions, which will validate and redefine the current recommendations. They will also advise on studies which may provide the information needed in those clinical areas where there is currently insufficient published data on which to base any practical advice, such as the use of fluoroquinolones in minor companion animal species.
The REQUEST initiative is supported by Vetoquinol, a global supplier of fluoroquinolone medicines to the veterinary community. Further support is provided by the healthcare consultancy StratAdviser Ltd, which gives assistance on methodology and other scientific matters and also guarantees the independence of the expert group.
The webinars each last between three and five minutes and are part of the 2016 ‘Talk About Laminitis’ disease awareness initiative to help detect, manage and monitor PPID.
The webinars can be viewed on the Boehringer Academy website – www.boehringer-academy.co.uk - and podcast versions are also available enabling veterinary professionals to listen to them ‘on the go’.
The first series includes:
The second webinar series covers:
For further information on the webinars or podcasts visit www.boehringer-academy.co.uk or contact your local Boehringer Ingelheim territory manager.
John said: "This is a great opportunity to raise awareness for what is a very serious problem in our profession - we all know someone within the veterinary community who has had mental health problems - and I am very proud that it is a strong community trying to tackle this issue.
"But it is not just about one day – we can’t forget about it for the rest of the year. We all live extremely busy lives and if we are not functioning as people, we are not going to function as professionals."
John says veterinary professionals must take a balanced and holistic view of their lives and develop strong teams at local, regional, national and even international level, to build resilience in dealing with stress and dispelling the stigma about mental illness that may prevent people seeking help.
Mental ill-health will affect one in four people over the next 12 months[i] and in England, one in six people experience a common mental health problem (such as anxiety and depression) in any given week[ii]. There are particular issues within the veterinary profession, with higher than average rates of suicide, and patterns of distress, anxiety and depression, among other illnesses.
The BSAVA will launch a new ‘Beyond the Clinics’ personal development stream at Congress next April, including a non-clinical series of lectures on physical and mental health, and, with RCVS, it hosts a series of Mind Matters CPD courses across all 12 regions – all of which were sold out in 2016.
John added: "I’m looking forward to inviting colleagues to Beyond The Clinics on the Sunday of Congress, which is a great opportunity for the whole profession to think more deeply about how we look after each other, by increasing knowledge about mental wellbeing, building resilience in dealing with stress and dispelling the stigma about mental illness that may prevent people seeking help.
"I’m also very proud of the BSAVA’s involvement in the Mind Matters initiative, set up by the Royal College of Veterinary Surgeons. All 12 of our regions hosted sold out courses during 2016, which is part of the profession’s response to research showing that the stress of working in modern veterinary practices has taken a heavy toll on the mental wellbeing of many staff."
Limited places are available for the BSAVA’s Mind Matters regional meetings – more information is available at www.bsava.com/Education/CPD/Mind-Matters
The meetings provide training for all members of the practice team to help them recognise any signs of mental problems in their colleagues – and, perhaps, in themselves. The training aims to help individuals know how to communicate with people they are concerned about and offers tips on stress management and staying well.
John, who has suffered mental health difficulties himself, says it is important to reach out and respond as a profession to this serious problem.
"My main advice is to be aware of others, be supportive, understand and appreciate them, notice when someone isn’t acting normally, and also remember that you are in a team together with people to talk to and you should do that. You can’t take stress away completely but you can’t put everything on the practice owner, this is a whole team responsibility – upwards, sidewards and downwards."
References
The 12-strong crew, aged between 18 and 60, left Marina San Miguel, Tenerife on 22nd March and rowed 2,875 nautical miles across the Atlantic Ocean, arriving in Falmouth Harbour, Antigua 42 days, 2 hours and 30 minutes later.
Each of the crew of the 12-metre boat, Roxy, rowed more than 1.5million strokes and burned over 5000 calories a day.
During the journey, the team had to battle with ocean storms and seasickness, not to mention extreme blisters and callouses. Simon lost almost 10kg.
Simon, who was a rowing novice before this, raised almost £15,000 for MacMillan Cancer Support. He said: "It’s without a doubt the hardest thing I’ve ever done. I can’t put into words how I’m feeling right now. The sense of achievement is a little overwhelming.
"The journey was everything I wanted it to be - tough both physically and mentally but hugely rewarding and one thing is for sure, I wouldn’t be standing here at the finish line if it hadn’t been for each and every one of the incredible crew. What a gorgeous group of people who will remain lifelong friends. After catching up with my family, the thing I was most looking forward to was a good meal!”.
The crew were welcomed to Antigua by a flotilla of smaller boats with many of the crew’s families onboard, before a reception at the Antigua Yacht Club.
MSD Animal Health has announced the launch of KBHH Yard Master – a new preventative healthcare and biosecurity app - as part of its ongoing Keeping Britain’s Horses Healthy (KBHH) campaign.
MSD says KBHH Yard Master has been created to link vets and yards where the majority of horses in Britain are kept. It aims to play a key role in protecting the health and welfare of the herd and in safeguarding the yard’s reputation and business.
Peter Young, Equine Business Manager at MSD Animal Health said: "Good biosecurity is essential in building and maintaining the reputation of a yard which, in turn, impacts on owner satisfaction and retention. It remains, however, a poorly understood subject despite its importance. We’ve therefore invested in the creation of KBHH Yard Master to help vets, yard managers, their employees and horse owners focus on preventative health and biosecurity measures; making best practice seem more achievable and easier to implement.
He added: "We were also fortunate to have input from Professor Josh Slater, who has been heavily involved in developing the content, evaluation and grading system behind the app assessment."
KBHH Yard Master covers all aspects of biosecurity, including everyday husbandry practices, managing new arrivals, running isolation facilities, infection control and personnel movement. MSD says it will frame a dialogue with yard managers regarding preventative healthcare and biosecurity in situ and provide instant feedback on current practices and risk. Following the on-site assessment, a report can be sent to the yard manager with tailor-made recommendations and timings, detailing how they can improve their yard’s biosecurity performance.
Peter added: "Based on the data gathered through the KBHH campaign we know that approximately half of horses are vaccinated for ‘flu. This means that there will be horses on yards, visited by vets, that are not vaccinated. KBHH Yard Master will help identify those horses and allow the vet to recommend appropriate vaccination schedules."
MSD has produced a range of supporting KBHH Yard Master materials to promote understanding, participation and compliance amongst yard staff and owners, including posters and downloadable booklets which explain aspects such as disease prevention, infection control and outbreak control.
A certificate of excellence is also available to be awarded to those yards which, following assessment, have a low overall biosecurity risk.
For more information, contact your MSD Animal Health Equine Account Manager or call MSD on 01908 685685.
BVA President Gudrun Ravetz said: "Veterinary View not only highlights some of the veterinary profession's fantastic work, but complements our joint project with RCVS, Vet Futures, in exploring how the profession can best shape its own future. We hope it will stimulate debate among vets, and the wider community in which we work, about both the big challenges and opportunities that the veterinary profession is facing."
The series includes a number of videos which showcase more recent industry developments:
Stem Cell therapy for the treatment of canine osteoarthritis (VetCell Therapeutics)
Pharmtrax, a mobile device for vets to record work and dispensing on the farm (Henry Schein Animal Health)
Hormone implants as an alternative to castration (Virbac Animal Health)
Practice management support from Zoetis
Preventing an epidemic of equine flu (Merial Animal Health)
During June, Vets Now’s 1300 employees up and down the country will focus on activities which make them feel happy and supported at work including; Feelgood Friday which inspires lunchtime yoga sessions and taking time to unwind, Workout Wednesday which will see teams across the country taking 10,000 steps, and encouraging colleague picnics outside on National Picnic Day (18th June).
The company has also enlisted the help of nutritionist Lily Soutter (pictured right), a regular on ITV’s This Morning, to devise healthy and quick recipes for busy shift-working vets and vet nurses.
Laura Black, Vets Now’s head of health, safety and wellbeing said: "The issue of mental health is more prevalent than ever in the veterinary profession and we recognise that out-of-hours work, in particular, can present its challenges.
"That’s why, as an organisation, health and wellbeing is one of our key priorities. So whilst our Wellness Month has some fun elements, the overall goal is to make sure our teams feel they are supported at work."
The webinars will provide practical information to help manage renal cases, focusing on the importance of early diagnosis.
Led by feline medicine experts, Dr Tommaso Furlanello PhD ECVCP Dip and Dr Sarah Caney BVSc PhD DSAM(Feline) MRCVS, the webinars will provide practical information to help manage renal cases.
On 7th June, Tommaso's talk will address early diagnosis of feline chronic kidney disease (CKD) and recognition and management of its complications.
On the 28th, Sarah's talk will focus on supporting and communicating with cat owners around early diagnosis and achieving optimal long-term management.
The webinars will be available to watch live or as a recording after the event.
To register for the event, visit: https://purinaproplan-webinarseries.vfairs.com/
If you attend the live event, you'll have the chance to put questions to Sarah and Tommaso, but if you can't make it on the night, there'll be a recording afterwards.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
The University of Surrey has announced that it is to launch a new school of veterinary medicine in 2014.
According to the University, the new school will embrace the 'One Health - One Medicine' philosophy and will include the development of a unique research-led veterinary medicine degree programme with an emphasis on research, veterinary pathology and livestock medicine.
The new school will be based at the University of Surrey's Manor Park site in Guildford, in order to encourage collaboration of students and staff from different disciplines, with those studying towards a veterinary medicine qualification being exposed to engineering and physics as well as receiving training in core business skills.
The new School of Veterinary Medicine at Surrey will be delivered through collaborations with key partners including: the Animal Health and Veterinary Laboratories Agency (AHVLA), the BBSRC Pirbright Institute, the Veterinary Medicines Directorate (VMD), Fitzpatrick Referrals, Liphook Equine Hospital and Westpoint Farm Vets. The University says it is looking to extend its relationships with regional veterinary practices over the coming year.
Students will also be exposed to global issues concerning animal health through the University Global Partnership Network (UGPN), a trilateral agreement between Surrey, North Carolina State and São Paulo Universities through teaching collaborations, summer scholarships and research exchanges.
Professor Lisa Roberts, Dean of the Faculty of Health and Medical Sciences at the University of Surrey, said: "As a research-intensive University we have the expertise, reputation, technical and business skills which our students can benefit from, allowing us to train the veterinary leaders of the future. Combining state-of-the-art facilities, our unique partnerships and a campus location, the new School will provide a stimulating environment not only for undergraduates, but for the professional development training of qualified veterinary surgeons."
Professor John Fazakerley, Director of The Pirbright Institute, said: "This is good news for the UK veterinary research community. The Pirbright Institute currently works in close collaboration with the University of Surrey on research that benefits animal health and welfare; we very much look forward to building on this established and growing association as the new school of veterinary medicine is launched. There is an important place for trained veterinarians in scientific research and we are delighted that the University has decided to emphasise these areas in particular."
Professor Andy Durham of the Liphook Equine Hospital said: "The new School of Veterinary Medicine development programme at the University of Surrey is ideally timed to provide an alternative to the traditional veterinary education and to respond to the demands of a changing profession with fresh plans, ideas and enthusiasm. Enticing newly developed facilities make Guildford an excellent student town and with several collaborative specialist partners within the locality the new School of Veterinary Medicine is perfectly placed geographically to provide a veterinary education fitting for the 21st century."
The University is also in consultation with the Royal College of Veterinary Surgeons. Freda Andrews, Head of Education at the RCVS, said: "We were pleased to meet Professor Sir Christopher Snowden, President and Vice-Chancellor and his colleagues from the University of Surrey recently, and interested to hear their proposals to develop a new School of Veterinary Medicine. We will be working with them over the coming months to develop a timetable for considering the new programme against our accreditation standards. The monitoring process will take a number of years."
The University says it has already laid the foundations for the new School through its expansion of teaching and research activities in its Faculty of Health and Medical Sciences, including the launch of the BSc programme in Veterinary Biosciences in 2009 and in October of this year a new MSc in Veterinary Microbiology. A new MSc in Veterinary Pathology is also currently under development.
The University says that over the next 12 months it will be recruiting new academic staff, attracting the first cohort of students and beginning building works in preparation for the first cohort of students in 2014.
The VMD, which reclassified the product following a request from Zoetis, says that increasing the availability of this anthelmintic should help it to be incorporated into strategic worm control programmes on farms in line with best practice guidance on worm control. This could result in long term health benefits for sheep, for example by reducing the development and spread of anthelmintic resistance, thereby prolonging the effective use of anthelmintics.
However, both the British Veterinary Association and the Sheep Veterinary Society have expressed concerns over the move.
BVA Junior Vice President John Fishwick said: "We know that resistance to anthelmintics is increasing in grazing animals worldwide and needs to be addressed to avoid a potentially disastrous situation of being unable to tackle parasites. The reclassification of Startect Dual Active from POM-V to POM-VPS is in direct opposition to the trend in Europe, where we are seeing increased control over dispensing of anthelmintics in species where resistance is posing a serious threat to animal health, welfare and profitable production; we're extremely concerned that we might start seeing resistance develop in Group 4 as a result.
"BVA believes that the prescribing of anthelmintics requires a level of control best provided by a veterinary surgeon who has the animals under his/her care, and is based on a sound clinical diagnosis. The drugs are best used as part of a flock health plan drawn up by farmers in conjunction with their vet in order to protect animal health and welfare and safeguard the efficacy of these products for the future."
Sheep Veterinary Society President Kathryn Dun said: "Group 4 anthelmintics should be used only as part of a careful designed strategy for the individual farm and it is imperative that this strategy is worked out with a vet and is part of a flock health plan for that farm. The products need to be used, in the correct way, to help prolong the life of our other anthelmintics.
"We are unlikely to have any further new groups of anthelmintics in the foreseeable future, so education of those buying and selling these products is crucial to ensure the longevity of the effective action of them against sheep parasites."
Further information on BVA's policy on anthelmintics can be found here: www.bva.co.uk/news-campaigns-and-policy/policy/medicines/anthelmintics
The programme includes:
Chris Scudder will also be announcing the successful bids for funding from SAMSoc's new research grant initiative.
Co-organiser Caroline Kisielewicz (pictured right) said: "Despite the trials and tribulations of the ongoing pandemic, we are delighted that the spring SAMSoc meeting has returned this year! We are very excited about the upcoming meeting, which is packed full of great lectures that will stimulate some great talking points. Whilst it won't be the same as being there in person, we hope that everyone will enjoy connecting with colleagues and friends through the virtual world with what promises to be a fantastic event."
The association is also inviting entries now for the next poster/case report competition, details of which can be found at: https://www.samsoc.org/competitions/call-for-spring-2021-poster-entries.
The winning presentation will receive £250, and two runners up will each receive £100.
For the full programme, visit https://www.samsoc.org/meetings/2021-spring-meeting
Registration costs £100 for the day, with a discounted rate at £60 for SAMSoc members (membership costs £29).
To register, visit www.samsoc.org.
Andrew Robathan MP has opened Companion Care Vets latest surgery in Leicester, bringing the number of surgeries across the UK to 67.
The surgery is located within the brand new Pets at Home store at Fosse Park, and the joint veterinary partners are Shabbir Shariff and Sameer Bheda.
The surgery houses a full operating theatre, digital x-ray facilities, in-house laboratory and a hospital ward providing a full range of treatments from health checks to emergency operations.
Shabbir said: "I have always wanted to own my own surgery and jumped at the opportunity to work with Companion Care Vets."
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
The British Equine Veterinary Association (BEVA) has announced that it is reducing the cost of its CPD by 50% this year and making its webinars free to members.
David Mountford, Chief Executive of BEVA said: "Last year we were able to capitalise on some efficiencies in other areas of BEVA operations. We are delighted to be able to hand the resulting benefits directly back to our members across all our CPD programme during 2013."
The Association says its CPD covers a broad range of topics is aimed at busy vets who need to build CPD points, whether new graduates, equine or mixed practitioners. It takes the form of clinical workshops, regional meetings, nursing meetings, webinars and one, two and three day practical courses, held in the UK.
This year's courses include:
For more information, visit http://www.beva.org.uk/news-and-events/beva-courses or ring +44(0)1638 723555 or email info@beva.org.uk.
The new tool is part of a package that also includes posters and SMS texts to support veterinary practices in raising awareness of gastric ulcers to horse owners.
Equine Gastric Ulcer Syndrome (EGUS) is a serious and common condition and any type of horse can be at risk.1 EGUS can have a profound impact on a horse’s condition and performance and can be life threatening in foals. It is a challenging condition to diagnose as the clinical signs are often vague and not always present.1
Gastroscopy is the only method currently available for a definitive diagnosis. Of the two types of disease equine squamous gastric disease is graded on a numeric scale with 1 being the least severe and 4 being the most serious. Equine glandular gastric disease can be very varied in terms of location and type so grading this disease on a score system is no longer recommended. Instead it is now usually described in terms of location, severity and appearance.2
The new tool has been designed to help vets to map the area affected by gastric disease and record the details in an accessible format. This information, together with treatment and management recommendations, can be shared easily with the client. Posters explaining gastric ulceration have been designed to help increase awareness and understanding of EGUS amongst horse owners.
Zoetis says effective treatment usually involves a combination of management and medical treatments. UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.3 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.3,4 One syringe contains enough UlcerGold for a daily dose for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
'The new discovery in feline communication' symposium was held during the ISFM (International Society of Feline Medicine) International Feline Congress from 8th - 10th August.
The symposium was presented by Professor Patrick Pageat DVM MSc PhD HDR Dipl ECAWBM-BM Hon Dipl CLECVe, who researched and developed both Feliway and Adaptil, and Dr Andy Sparkes BVetMed PhD DipECVIM MANZCVS MRCVS, veterinary consultant at ISFM.
Patrick presented ‘the science behind the new pheromone discovery’ and covered how it was developed, how it works and why it is a step up from the existing pheromone products. Andy followed with ‘Feliway Optimum: clinical evidence’ and featured the clinical data behind the new product and how it outperforms existing pheromones.
To register for ‘the new discovery in feline communication’ symposium on demand, which equates to one hour’s CPD, email cevauk@ceva.com.